Editorial: Targeting the endocannabinoidome in neurodegenerative disorders

Editorial: Targeting the endocannabinoidome in neurodegenerative disorders

Bibliographic Details
Main Author:	Hiroki Ishiguro
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-01-01
Series:	Frontiers in Aging Neuroscience
Subjects:	endocannabinoid expanded endocannabinoid system cannabinoid CB2 receptor Alzheimer's Disease Parkinson's Disease N-Oleoyl-glycine
Online Access:	https://www.frontiersin.org/articles/10.3389/fnagi.2022.1116635/full

Similar Items

Targeting the Endocannabinoidome in Pancreatic Cancer
by: Valerio Falasca, et al.
Published: (2022-02-01)

New Insights and Potential Therapeutic Targeting of CB2 Cannabinoid Receptors in CNS Disorders
by: Berhanu Geresu Kibret, et al.
Published: (2022-01-01)

Distinctive Evidence Involved in the Role of Endocannabinoid Signalling in Parkinson’s Disease: A Perspective on Associated Therapeutic Interventions
by: Tapan Behl, et al.
Published: (2020-08-01)

Therapeutic Potential of Cannabidiol (CBD) for Skin Health and Disorders
by: Baswan SM, et al.
Published: (2020-12-01)

Cannabinoid CB2 Receptors in Neurodegenerative Proteinopathies: New Insights and Therapeutic Potential
by: Barbara Vuic, et al.
Published: (2022-11-01)

Editorial: The Canonical and Non-Canonical Endocannabinoid System as a Target in Cancer and Acute and Chronic Pain
by: Marialessandra Contino, et al.
Published: (2020-03-01)

Endocannabinoid System Components as Potential Biomarkers in Psychiatry
by: Francisco Navarrete, et al.
Published: (2020-04-01)

Cannabinoid Receptor Modulation of Neurogenesis: ST14A Striatal Neural Progenitor Cells as a Simplified In Vitro Model
by: Erika Cottone, et al.
Published: (2021-03-01)

Cannabinoid CB2 receptors and spinal microglia are implicated in tingenone-mediated antinociception in mice
by: Clarice C.V. Moura, et al.
Published: (2021-01-01)

The Role of Cannabinoids in the Setting of Cirrhosis
by: Pratima Dibba, et al.
Published: (2018-06-01)

Endocannabinoid System and Exogenous Cannabinoids in Depression and Anxiety: A Review
by: Ahmed Hasbi, et al.
Published: (2023-02-01)

The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet?
by: Estefanía Moreno, et al.
Published: (2019-04-01)

Cannabinoids in Medicine: A Multifaceted Exploration of Types, Therapeutic Applications, and Emerging Opportunities in Neurodegenerative Diseases and Cancer Therapy
by: Victor Voicu, et al.
Published: (2023-09-01)

Cannabinoids and Their Receptors in Skin Diseases
by: Eun Hee Yoo, et al.
Published: (2023-11-01)

Minor Cannabinoids: Biosynthesis, Molecular Pharmacology and Potential Therapeutic Uses
by: Kenneth B. Walsh, et al.
Published: (2021-11-01)

The Endocannabinoid System and Cannabidiol: Past, Present, and Prospective for Cardiovascular Diseases
by: Martina Rabino, et al.
Published: (2021-09-01)

Neuronal Calcium and cAMP Cross-Talk Mediated by Cannabinoid CB1 Receptor and EF-Hand Calcium Sensor Interactions
by: Edgar Angelats, et al.
Published: (2018-07-01)

Cannabinoids and PPAR Ligands: The Future in Treatment of Polycystic Ovary Syndrome Women with Obesity and Reduced Fertility
by: Piotr Przybycień, et al.
Published: (2022-08-01)

The role of endocannabinoids system in fatty liver disease and therapeutic potentials
by: Khalid A Alswat
Published: (2013-01-01)

Osteogenic growth peptide is a potent anti-inflammatory and bone preserving hormone via cannabinoid receptor type 2
by: Bitya Raphael-Mizrahi, et al.
Published: (2022-05-01)

Chemism and the role of endocannabinoids in physiological processes
by: Prerad Ranka, et al.
Published: (2017-01-01)

Potential Role of Cannabinoid Type 2 Receptors in Neuropsychiatric and Neurodegenerative Disorders
by: Hiroki Ishiguro, et al.
Published: (2022-06-01)

Methylhonokiol attenuates neuroinflammation: a role for cannabinoid receptors?
by: Gertsch Jürg, et al.
Published: (2012-06-01)

Evaluation of cannabinoid receptors type 1–2 in periodontitis patients
by: Atefe Ataei, et al.
Published: (2022-10-01)

The Endocannabinoid System: A Potential Therapeutic Target for Coagulopathies
by: Wujood Khayat, et al.
Published: (2022-06-01)

Mechanisms of Broad-Spectrum Antiemetic Efficacy of Cannabinoids against Chemotherapy-Induced Acute and Delayed Vomiting
by: Nissar A. Darmani
Published: (2010-09-01)

Orexin-A/Hypocretin-1 Controls the VTA-NAc Mesolimbic Pathway via Endocannabinoid-Mediated Disinhibition of Dopaminergic Neurons in Obese Mice
by: Lea Tunisi, et al.
Published: (2021-02-01)

Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis
by: Ana Cabranes, et al.
Published: (2005-11-01)

The Expanded Endocannabinoid System Contributes to Metabolic and Body Mass Shifts in First-Episode Schizophrenia: A 5-Year Follow-Up Study
by: Madis Parksepp, et al.
Published: (2022-01-01)

Potential Therapeutic Targets to Modulate the Endocannabinoid System in Alzheimer’s Disease
by: Hina Kanwal, et al.
Published: (2024-04-01)

1-(2′,4′-dichlorophenyl)-6-methyl-N-cyclohexylamine-1,4-dihydroindeno[1,2-c]pyrazole-3-carboxamide, a novel CB2 agonist, alleviates neuropathic pain through functional microglial changes in mice
by: L. Luongo, et al.
Published: (2010-01-01)

Cannabinomimetric Lipids: From Natural Extract to Artificial Synthesis
by: Ya-Ru Gao, et al.
Published: (2018-01-01)

The expression of cannabinoid type 1 receptor and 2-arachidonoyl glycerol synthesizing/degrading enzymes is altered in basal ganglia during the active phase of levodopa-induced dyskinesia
by: Estefania Rojo-Bustamante, et al.
Published: (2018-10-01)

Role of the Endocannabinoid System in Metabolic Control Processes and in the Pathogenesis of Metabolic Syndrome: An Update
by: Gabriella Dörnyei, et al.
Published: (2023-01-01)

The Therapeutic Potential of the Endocannabinoid System in Age-Related Diseases
by: Ivona Maria Tudorancea, et al.
Published: (2022-10-01)

The Expression of the Endocannabinoid Receptors CB2 and GPR55 Is Highly Increased during the Progression of Alzheimer’s Disease in <i>App<sup>NL-G-F</sup></i> Knock-In Mice
by: Dina Medina-Vera, et al.
Published: (2023-05-01)

Down-Regulation of Cannabinoid Type 1 (CB1) Receptor and its Downstream Signaling Pathways in Metastatic Colorectal Cancer
by: Valeria Tutino, et al.
Published: (2019-05-01)

The Absence of the Transient Receptor Potential Vanilloid 1 Directly Impacts on the Expression and Localization of the Endocannabinoid System in the Mouse Hippocampus
by: Jon Egaña-Huguet, et al.
Published: (2021-02-01)

Endocannabinoids in stressed humans
by: Gustav Schelling
Published: (2012-09-01)

Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents
by: Daniel A. Ladin, et al.
Published: (2016-10-01)